Approval · Notice of Compliance 2090 · 1999
CROWN-TIM: Notice of Compliance 2090
Issued January 12, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2090
- Date
- January 12, 1999
- Company
- Crownpharma Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Elevated intraocular pressure therapy
- Canadian reference product
- TIMOPTIC (Merck Sharp & Dohme)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CROWN-TIM | 02239301 | — |
| CROWN-TIM | 02239300 | — |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per ML
- TIMOLOL MALEATE 2.5 MG per ML